Categories: Tech

Revenera Achieves ISO 27001 Certification of its Information Security Management System (ISMS)

ITASCA, Ill., July 09, 2025 (GLOBE NEWSWIRE) — Revenera, a division of Flexera Software LLC and producer of innovative platforms that help technology companies build better products, accelerate time-to-value, and monetize what matters, today announced its ISO 27001 (ISO/IEC 27001) certification for the Information Security Management System (ISMS) supporting the assets, technologies and processes employed by Revenera for processing, management, and delivery of its software monetization, entitlement management and monetization services to its customers, including FlexNet Operations, FlexNet Embedded, and FlexNet Publisher. The certification was performed by Schellman Compliance, LLC, an ANAB- and UKAS- accredited certification body based in the United States.

ISO 27001 is a globally recognized standard for the establishment and certification of an information security management system (ISMS). The standard specifies the requirements for establishing, implementing, operating, monitoring, reviewing, maintaining and improving a documented ISMS within the context of the organization’s overall business risks. It sets forth a risk-based approach that focuses on adequate and proportionate security controls that protect information assets and give confidence to interested parties.

To achieve the certification, Revenera demonstrated its systematic and ongoing approach to managing sensitive company and customer information through its software monetization platform, entitlement management and licensing solutions. As a result, these products are now recognized as fully compliant with the International Organization for Standardization (ISO) 27001 global security standard. Revenera also established a formal program to maintain the certification.

“Revenera is a leader in helping software suppliers to drive top line revenue with modern software monetization and understand usage and compliance with software usage analytics,” said Conal Gallagher, CIO & CISO at Flexera. “This ISO certification assures each of our software supplier customers that both their data and their end customers’ data are secure and meets the rigorous international standard.”

Certificate Verification

The details of Revenera’s ISMS certification are publicly available here.

About Revenera

Revenera helps product executives build better products, accelerate time to value and monetize what matters. Revenera’s leading solutions help software and technology companies drive top line revenue with modern software monetization, understand usage and compliance with software usage analytics, empower the use of open source with software composition analysis and deliver an excellent user experience—for embedded, on-premises, cloud and SaaS products. To learn more, visit www.revenera.com.

 
GlobeNews Wire

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

4 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago